300 related articles for article (PubMed ID: 36362293)
1. Cyclodextrin-Based Polymeric Materials Bound to Corona Protein for Theranostic Applications.
Esmaeilpour D; Broscheit JA; Shityakov S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362293
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular polymeric materials via cyclodextrin-guest interactions.
Harada A; Takashima Y; Nakahata M
Acc Chem Res; 2014 Jul; 47(7):2128-40. PubMed ID: 24911321
[TBL] [Abstract][Full Text] [Related]
3. Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems.
Shelley H; Babu RJ
J Pharm Sci; 2018 Jul; 107(7):1741-1753. PubMed ID: 29625157
[TBL] [Abstract][Full Text] [Related]
4. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
Lakkakula JR; Maçedo Krause RW
Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
[TBL] [Abstract][Full Text] [Related]
5. Multifunctionality of cyclodextrin-based polymeric nanoparticulate delivery systems for chemotherapeutics, combination therapy, and theranostics.
Devi LS; Casadidio C; Gigliobianco MR; Di Martino P; Censi R
Int J Pharm; 2024 Apr; 654():123976. PubMed ID: 38452831
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
Zafar N; Fessi H; Elaissari A
Int J Pharm; 2014 Jan; 461(1-2):351-66. PubMed ID: 24342710
[TBL] [Abstract][Full Text] [Related]
7. Drug Carrier Systems Based on Cyclodextrin Supramolecular Assemblies and Polymers: Present and Perspectives.
Gonzalez-Gaitano G; Isasi JR; Velaz I; Zornoza A
Curr Pharm Des; 2017; 23(3):411-432. PubMed ID: 27855609
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
Li J; Loh XJ
Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications.
van de Manakker F; Vermonden T; van Nostrum CF; Hennink WE
Biomacromolecules; 2009 Dec; 10(12):3157-75. PubMed ID: 19921854
[TBL] [Abstract][Full Text] [Related]
10. Prospects of charged cyclodextrins in biomedical applications.
Sehgal V; Pandey SP; Singh PK
Carbohydr Polym; 2024 Jan; 323():121348. PubMed ID: 37940240
[TBL] [Abstract][Full Text] [Related]
11. Polymeric Nanocarriers Based on Cyclodextrins for Drug Delivery: Host-Guest Interaction as Stimuli Responsive Linker.
Peng L; Liu S; Feng A; Yuan J
Mol Pharm; 2017 Aug; 14(8):2475-2486. PubMed ID: 28463008
[TBL] [Abstract][Full Text] [Related]
12. Advances in the development of cyclodextrin-based nanogels/microgels for biomedical applications: Drug delivery and beyond.
Topuz F; Uyar T
Carbohydr Polym; 2022 Dec; 297():120033. PubMed ID: 36184144
[TBL] [Abstract][Full Text] [Related]
13. Interactions of Native Cyclodextrins with Metal Ions and Inorganic Nanoparticles: Fertile Landscape for Chemistry and Materials Science.
Prochowicz D; Kornowicz A; Lewiński J
Chem Rev; 2017 Nov; 117(22):13461-13501. PubMed ID: 29048880
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic cyclodextrin nanoparticles.
Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
[TBL] [Abstract][Full Text] [Related]
15. Research Progress on Synthesis and Application of Cyclodextrin Polymers.
Liu Y; Lin T; Cheng C; Wang Q; Lin S; Liu C; Han X
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669556
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
Muankaew C; Loftsson T
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
[TBL] [Abstract][Full Text] [Related]
17. Colloidal particles containing labeling agents and cyclodextrins for theranostic applications.
Zafar N; Fessi H; Elaissari A
Int J Pharm; 2014 Sep; 472(1-2):118-29. PubMed ID: 24914830
[TBL] [Abstract][Full Text] [Related]
18. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
Parrot-Lopez H; Perret F; Bertino-Ghera B
Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin-functionalized polymers as drug carriers for cancer therapy.
Wei H; Yu CY
Biomater Sci; 2015 Jul; 3(7):1050-60. PubMed ID: 26221939
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-based delivery systems in parenteral formulations: A critical update review.
Ferreira L; Campos J; Veiga F; Cardoso C; Paiva-Santos AC
Eur J Pharm Biopharm; 2022 Sep; 178():35-52. PubMed ID: 35868490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
